Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Yalkinoglu Ö"'
Autor:
Eslami M; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Schuepbach-Mallepell S; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Diana D; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Willen L; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Kowalczyk-Quintas C; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Desponds C; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Peter B; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Vigolo M; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Renevey F; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Donzé O; AdipoGen Life Sciences, Epalinges 1066, Switzerland., Luther SA; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Yalkinoglu Ö; Clinical Pharmacology, Global Early Development, The Healthcare Business of Merck KGaA, Darmstadt 64293, Germany., Alouche N; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland., Schneider P; Department of Immunobiology, University of Lausanne, Epalinges 1066, Switzerland.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Jul 16; Vol. 121 (29), pp. e2404309121. Date of Electronic Publication: 2024 Jul 11.
Autor:
Klopp-Schulze L; the healthcare business of Merck KGaA, Darmstadt, Germany., Gopalakrishnan S; the healthcare business of Merck KGaA, Darmstadt, Germany., Yalkinoglu Ö; the healthcare business of Merck KGaA, Darmstadt, Germany., Kuroki Y; Merck Biopharma Co., Ltd., Tokyo, Japan (an affiliate of Merck KGaA, Darmstadt, Germany)., Lu H; Merck Serono Co., Ltd., Beijing, China (an affiliate of Merck KGaA, Darmstadt, Germany)., Goteti K; EMD Serono, Billerica, Massachusetts, USA., Krebs-Brown A; the healthcare business of Merck KGaA, Darmstadt, Germany., Nogueira Filho M; the healthcare business of Merck KGaA, Darmstadt, Germany., Gradhand U; the healthcare business of Merck KGaA, Darmstadt, Germany., Fluck M; the healthcare business of Merck KGaA, Darmstadt, Germany., Shaw J; EMD Serono, Billerica, Massachusetts, USA., Dong J; EMD Serono, Billerica, Massachusetts, USA., Venkatakrishnan K; EMD Serono, Billerica, Massachusetts, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Jun; Vol. 115 (6), pp. 1346-1357. Date of Electronic Publication: 2024 Feb 28.
Autor:
van der Plas JL; Centre for Human Drug Research, Leiden, Netherlands; Department of Infectious Diseases and Parasitology, Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., Kuiper VP; Department of Infectious Diseases and Parasitology, Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., Bagchus WM; Merck Institute for Pharmacometrics, Merck Serono (an affiliate of Merck KGaA, Darmstadt, Germany), Lausanne, Switzerland., Bödding M; The healthcare business of Merck KGaA, Darmstadt, Germany., Yalkinoglu Ö; The healthcare business of Merck KGaA, Darmstadt, Germany., Tappert A; The healthcare business of Merck KGaA, Darmstadt, Germany., Seitzinger A; The healthcare business of Merck KGaA, Darmstadt, Germany., Spangenberg T; Global Health Institute of Merck, Ares Trading (a subsidiary of Merck KGaA, Darmstadt, Germany), Eysins, Switzerland., Bezuidenhout D; Merck (Pty) (an affiliate of Merck KGaA, Darmstadt, Germany), Modderfontein, South Africa., Wilkins J; Occams, Amstelveen, Netherlands., Oeuvray C; Global Health Institute of Merck, Ares Trading (a subsidiary of Merck KGaA, Darmstadt, Germany), Eysins, Switzerland., Dhingra SK; Hemogenyx Pharmaceuticals, New York, NY, USA., Thathy V; Department of Microbiology & Immunology, Columbia University Irving Medical Center, New York, NY, USA., Fidock DA; Department of Microbiology & Immunology, Columbia University Irving Medical Center, New York, NY, USA; Center for Malaria Therapeutics and Antimicrobial Resistance, Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Smidt LCA; Centre for Human Drug Research, Leiden, Netherlands., Roozen GVT; Department of Infectious Diseases and Parasitology, Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., Koopman JPR; Department of Infectious Diseases and Parasitology, Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., Lamers OAC; Department of Infectious Diseases and Parasitology, Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., Sijtsma J; Department of Infectious Diseases and Parasitology, Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., van Schuijlenburg R; Department of Infectious Diseases and Parasitology, Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., Wessels E; Department of Medical Microbiology, Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., Meij P; Center for Cell and Gene Therapy, Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., Kamerling IMC; Centre for Human Drug Research, Leiden, Netherlands; Department of Infectious Diseases and Parasitology, Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., Roestenberg M; Department of Infectious Diseases and Parasitology, Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands. Electronic address: m.roestenberg@lumc.nl., Khandelwal A; The healthcare business of Merck KGaA, Darmstadt, Germany.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Oct; Vol. 23 (10), pp. 1164-1174. Date of Electronic Publication: 2023 Jul 03.
Autor:
Yalkinoglu Ö; Clinical Pharmacology, Quantitative Pharmacology, the healthcare business of Merck KGaA, Darmstadt, Germany., Becker A; Clinical Pharmacology, Quantitative Pharmacology, the healthcare business of Merck KGaA, Darmstadt, Germany., Krebs-Brown A; Global Biostatistics, Epidemiology and Medical Writing, the healthcare business of Merck KGaA, Darmstadt, Germany., Vetter C; Clinical Pharmacology, Quantitative Pharmacology, the healthcare business of Merck KGaA, Darmstadt, Germany., Lüpfert C; Clinical Pharmacology, Quantitative Pharmacology, the healthcare business of Merck KGaA, Darmstadt, Germany., Perrin D; NCE DMPK, Discovery and Development Technologies, the healthcare business of Merck KGaA, Darmstadt, Germany., Heuer J; Clinical Services, Nuvisan GmbH, Neu-Ulm, Germany., Biedert H; LC/MS Bioanalysis, Nuvisan GmbH, Neu-Ulm, Germany., Hirt S; LC/MS Bioanalysis, Nuvisan GmbH, Neu-Ulm, Germany., Bytyqi A; Clinical Pharmacology, Quantitative Pharmacology, the healthcare business of Merck KGaA, Darmstadt, Germany., Bachmann A; Clinical Pharmacology, Quantitative Pharmacology, the healthcare business of Merck KGaA, Darmstadt, Germany., Strotmann R; Clinical Pharmacology, Quantitative Pharmacology, the healthcare business of Merck KGaA, Darmstadt, Germany. Rainer.Strotmann@emdserono.com.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2023 Aug; Vol. 41 (4), pp. 596-605. Date of Electronic Publication: 2023 Jul 06.
Autor:
Pitsiu M; Quantitative Pharmacology and Pharmacometrics, ICON Clinical Research UK Ltd, Marlow, UK., Yalkinoglu Ö; Translational Medicine, the healthcare business of Merck KGaA, Darmstadt, Germany., Farrell C; Quantitative Pharmacology and Pharmacometrics, ICON Clinical Research UK Ltd, Marlow, UK., Girard P; Merck Institute of Pharmacometrics, Lausanne, Switzerland, an Affiliate of Merck KGaA, Darmstadt, Germany, Ares Trading S.A., Lausanne, Switzerland., Vazquez-Mateo C; Global Clinical Development, EMD Serono, Billerica, Massachusetts, USA., Papasouliotis O; Merck Institute of Pharmacometrics, Lausanne, Switzerland, an Affiliate of Merck KGaA, Darmstadt, Germany, Ares Trading S.A., Lausanne, Switzerland.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Aug; Vol. 12 (8), pp. 1157-1169. Date of Electronic Publication: 2023 Jun 18.
Autor:
Yin X; EMD Serono Research & Development Institute, Inc. (an Affiliate of Merck KGaA), 45 Middlesex Turnpike, Billerica, MA, 01821, USA. xiaoyan.a.yin@emdserono.com., Li Y; EMD Serono Research & Development Institute, Inc. (an Affiliate of Merck KGaA), 45 Middlesex Turnpike, Billerica, MA, 01821, USA., Bagchus W; WMB: Merck Serono S.A (an Affiliate of Merck KGaA), Lausanne, Switzerland., Yalkinoglu Ö; Merck KGaA, Darmstadt, Germany., Bezuidenhout D; WMB: Merck Serono S.A (an Affiliate of Merck KGaA), Lausanne, Switzerland., Tappert A; Merck KGaA, Darmstadt, Germany., McCarthy J; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and the Royal Melbourne Hospital, Melbourne, VIC, Australia., Marquart L; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; School of Public Health, University of Queensland, Brisbane, Australia., Oeuvray C; The Global Health Institute of Merck (an Affiliate of Merck KGaA), Eysins, Switzerland.
Publikováno v:
Malaria journal [Malar J] 2023 Jun 28; Vol. 22 (1), pp. 199. Date of Electronic Publication: 2023 Jun 28.
Autor:
Eslami M; Department of Immunobiology, University of Lausanne, Epalinges, Switzerland., Willen D; Clinical Pharmacology, Translational Medicine, Merck Healthcare KGaA, Darmstadt, Germany., Papasouliotis O; Translational Medicine, Merck Institute for Pharmacometrics (an affiliate of Merck KGaA), Lausanne, Switzerland., Schuepbach-Mallpell S; Department of Immunobiology, University of Lausanne, Epalinges, Switzerland., Willen L; Department of Immunobiology, University of Lausanne, Epalinges, Switzerland., Donzé O; Adipogen Life Sciences, Epalinges, Switzerland., Yalkinoglu Ö; Clinical Pharmacology, Translational Medicine, Merck Healthcare KGaA, Darmstadt, Germany., Schneider P; Department of Immunobiology, University of Lausanne, Epalinges, Switzerland.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Dec 02; Vol. 13, pp. 1035556. Date of Electronic Publication: 2022 Dec 02 (Print Publication: 2022).
Autor:
Khandelwal A; The healthcare business of Merck KGaA, Darmstadt, Germany. akash.khandelwal@emdgroup.com., Arez F; iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal.; Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal., Alves PM; iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal.; Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal., Badolo L; The healthcare business of Merck KGaA, Darmstadt, Germany., Brito C; iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal.; Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal., Fischli C; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Fontinha D; Faculdade de Medicina, Instituto de Medicina Molecular João Lobo Antunes, Universidade de Lisboa, Lisboa, Portugal., Oeuvray C; Global Health Institute of Merck, Ares Trading S.A (a subsidiary of Merck KGaA, Darmstadt, Germany), Eysins, Switzerland., Prudêncio M; Faculdade de Medicina, Instituto de Medicina Molecular João Lobo Antunes, Universidade de Lisboa, Lisboa, Portugal., Rottmann M; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Wilkins J; Occams, Amstelveen, The Netherlands., Yalkinoglu Ö; The healthcare business of Merck KGaA, Darmstadt, Germany., Bagchus WM; Merck Institute for Pharmacometrics, MerckSerono S.A. (an affiliate of Merck KGaA Darmstadt, Germany), Lausanne, Switzerland., Spangenberg T; Global Health Institute of Merck, Ares Trading S.A (a subsidiary of Merck KGaA, Darmstadt, Germany), Eysins, Switzerland. thomas.spangenberg@emdgroup.com.
Publikováno v:
Malaria journal [Malar J] 2022 May 15; Vol. 21 (1), pp. 151. Date of Electronic Publication: 2022 May 15.
Autor:
Shibeshi W; Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. workineh.shibeshi@aau.edu.et.; Global Health Institute of Merck, Ares Trading S.A., A subsidiary of Merck KGaA, Darmstadt, Germany. workineh.shibeshi@aau.edu.et., Bagchus W; Translational Medicine, Merck Serono S.A., An Affiliate of Merck KGaA, Darmstadt, Germany., Yalkinoglu Ö; Translational Medicine, Merck Healthcare KGaA, Darmstadt, Germany., Tappert A; Global Patient Safety, Merck Healthcare KGaA, Darmstadt, Germany., Engidawork E; Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Oeuvray C; Global Health Institute of Merck, Ares Trading S.A., A subsidiary of Merck KGaA, Darmstadt, Germany.
Publikováno v:
BMC infectious diseases [BMC Infect Dis] 2021 Dec 20; Vol. 21 (1), pp. 1274. Date of Electronic Publication: 2021 Dec 20.
Autor:
McCarthy JS; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and the Royal Melbourne Hospital, Melbourne, VIC, Australia., Yalkinoglu Ö; the healthcare business of Merck KGaA, Darmstadt, Germany., Odedra A; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; Liverpool School of Tropical Medicine, Liverpool, UK., Webster R; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Oeuvray C; The Global Health Institute of Merck (an affiliate of Merck KGaA), Eysin, Switzerland., Tappert A; the healthcare business of Merck KGaA, Darmstadt, Germany., Bezuidenhout D; Merck (an affiliate of Merck KGaA), Modderfontein, South Africa., Giddins MJ; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA., Dhingra SK; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA., Fidock DA; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Marquart L; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Webb L; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Yin X; Global Statistics for NDD, Immunology, Endocrinology, Fertility & Others, EMD Serono, Billerica, MA, USA., Khandelwal A; the healthcare business of Merck KGaA, Darmstadt, Germany., Bagchus WM; Merck Institute for Pharmacometrics, Lausanne, Switzerland. Electronic address: wilhelmina.bagchus@merckgroup.com.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Dec; Vol. 21 (12), pp. 1713-1724. Date of Electronic Publication: 2021 Oct 26.